NORDynamIC Study Group
Quick facts
Marketed products
- Peginterferon alfa-2a 40KD and Ribavirin · Virology / Hepatology
Peginterferon alfa-2a activates interferon-alpha receptors to enhance antiviral immunity, while ribavirin inhibits viral RNA synthesis, together suppressing hepatitis C virus replication.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: